11/20/2024 5:04 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 5:04 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 5:05 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 4:54 PM | Atara Biotherapeutics (Subject) Henrich Jill (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 4:55 PM | Atara Biotherapeutics (Subject) Hyllengren Eric J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 4:56 PM | Atara Biotherapeutics (Subject) Murugan Amar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 4:58 PM | Atara Biotherapeutics (Subject) Nguyen AnhCo (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/14/2024 5:10 PM | Atara Biotherapeutics (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024 12:29 PM | Atara Biotherapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 10:24 AM | Atara Biotherapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/15/2024 3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 4:03 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 5:42 PM | Adiumentum Capital Fund I GP LLC (Reporting) Adiumentum Capital Fund I LP (Reporting) Atara Biotherapeutics (Issuer) Ciongoli Gregory Austin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2024 3:07 PM | Adiumentum Capital Fund I LP (Filed by) Atara Biotherapeutics (Subject)
| Form SC 13D/A | |
09/04/2024 3:42 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
09/03/2024 4:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 5:26 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:27 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:27 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:27 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 5:27 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:00 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 4:10 PM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 4:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2024 3:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 3:32 PM | Atara Biotherapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/20/2024 4:04 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 7:30 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 5:18 PM | Adiumentum Capital Fund I LP (Filed by) Atara Biotherapeutics (Subject)
| Form SC 13D | |
05/20/2024 7:32 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:33 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:33 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:34 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:34 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 8:13 PM | Atara Biotherapeutics (Subject) Henrich Jill (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 8:13 PM | Atara Biotherapeutics (Subject) Hyllengren Eric J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 8:14 PM | Atara Biotherapeutics (Subject) Murugan Amar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 8:14 PM | Atara Biotherapeutics (Subject) Nguyen AnhCo (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 8:15 PM | Atara Biotherapeutics (Subject) Touchon Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 7:55 PM | Atara Biotherapeutics (Subject) Nguyen AnhCo (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024 3:20 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A | |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
04/26/2024 3:15 PM | Atara Biotherapeutics (Filer)
| Form DEF 14A | |
04/12/2024 3:15 PM | Atara Biotherapeutics (Filer) Atara Biotherapeutics (Filer)
| Form PRE 14A | |
04/02/2024 5:11 PM | Atara Biotherapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:12 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:12 PM | Atara Biotherapeutics (Issuer) Roncarolo Maria Grazia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:12 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:13 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 7:40 AM | Atara Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/28/2024 7:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 5:18 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:18 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:19 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:16 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:17 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:17 PM | Atara Biotherapeutics (Subject) Murugan Amar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:18 PM | Atara Biotherapeutics (Subject) Hyllengren Eric J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:19 PM | Atara Biotherapeutics (Subject) Henrich Jill (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:21 PM | Atara Biotherapeutics (Subject) Touchon Pascal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 7:13 PM | Atara Biotherapeutics (Subject) Nguyen Tran (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2024 3:45 PM | Atara Biotherapeutics (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
01/22/2024 12:58 PM | Atara Biotherapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Henrich Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Hyllengren Eric J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:40 PM | Atara Biotherapeutics (Issuer) Nguyen AnhCo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:41 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:28 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
01/09/2024 3:22 PM | Atara Biotherapeutics (Subject) BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G/A | |
01/08/2024 7:11 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |